CAR-T Therapy Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of CAR-T Therapy in Global, including the following market information:
Global CAR-T Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global CAR-T Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CD19 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CAR-T Therapy include Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech and Atara Biotherapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CAR-T Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAR-T Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global CAR-T Therapy Market Segment Percentages, by Type, 2021 (%)
Global CAR-T Therapy Market Segment Percentages, by Application, 2021 (%)
Global CAR-T Therapy Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies CAR-T Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies CAR-T Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global CAR-T Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global CAR-T Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CD19 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CAR-T Therapy include Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech and Atara Biotherapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CAR-T Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAR-T Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global CAR-T Therapy Market Segment Percentages, by Type, 2021 (%)
- CD19
- CD22
- Other
Global CAR-T Therapy Market Segment Percentages, by Application, 2021 (%)
- Acute Lymphocytic Leukemia
- Diffuse Large B Cell Lymphoma
- Follicular Lymphoma
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Other
Global CAR-T Therapy Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies CAR-T Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies CAR-T Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis AG
- Kite Pharma
- Pfizer
- Juno Therapeutics
- Celgene Corporation
- CARsgen Therapeutics
- Sorrento Therapeutics
- Legend Biotech
- Atara Biotherapeutics
- Aurora Biopharma
- Autolus Therapeutics PLC
- Bluebird
- Carina Biotech
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 CAR-T Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR-T Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CAR-T THERAPY OVERALL MARKET SIZE
2.1 Global CAR-T Therapy Market Size: 2021 VS 2028
2.2 Global CAR-T Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top CAR-T Therapy Players in Global Market
3.2 Top Global CAR-T Therapy Companies Ranked by Revenue
3.3 Global CAR-T Therapy Revenue by Companies
3.4 Top 3 and Top 5 CAR-T Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies CAR-T Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR-T Therapy Players in Global Market
3.6.1 List of Global Tier 1 CAR-T Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR-T Therapy Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global CAR-T Therapy Market Size Markets, 2021 & 2028
4.1.2 CD19
4.1.3 CD22
4.1.4 Other
4.2 By Type - Global CAR-T Therapy Revenue & Forecasts
4.2.1 By Type - Global CAR-T Therapy Revenue, 2017-2022
4.2.2 By Type - Global CAR-T Therapy Revenue, 2023-2028
4.2.3 By Type - Global CAR-T Therapy Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global CAR-T Therapy Market Size, 2021 & 2028
5.1.2 Acute Lymphocytic Leukemia
5.1.3 Diffuse Large B Cell Lymphoma
5.1.4 Follicular Lymphoma
5.1.5 Chronic Lymphocytic Leukemia
5.1.6 Multiple Myeloma
5.1.7 Other
5.2 By Application - Global CAR-T Therapy Revenue & Forecasts
5.2.1 By Application - Global CAR-T Therapy Revenue, 2017-2022
5.2.2 By Application - Global CAR-T Therapy Revenue, 2023-2028
5.2.3 By Application - Global CAR-T Therapy Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global CAR-T Therapy Market Size, 2021 & 2028
6.2 By Region - Global CAR-T Therapy Revenue & Forecasts
6.2.1 By Region - Global CAR-T Therapy Revenue, 2017-2022
6.2.2 By Region - Global CAR-T Therapy Revenue, 2023-2028
6.2.3 By Region - Global CAR-T Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America CAR-T Therapy Revenue, 2017-2028
6.3.2 US CAR-T Therapy Market Size, 2017-2028
6.3.3 Canada CAR-T Therapy Market Size, 2017-2028
6.3.4 Mexico CAR-T Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe CAR-T Therapy Revenue, 2017-2028
6.4.2 Germany CAR-T Therapy Market Size, 2017-2028
6.4.3 France CAR-T Therapy Market Size, 2017-2028
6.4.4 U.K. CAR-T Therapy Market Size, 2017-2028
6.4.5 Italy CAR-T Therapy Market Size, 2017-2028
6.4.6 Russia CAR-T Therapy Market Size, 2017-2028
6.4.7 Nordic Countries CAR-T Therapy Market Size, 2017-2028
6.4.8 Benelux CAR-T Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia CAR-T Therapy Revenue, 2017-2028
6.5.2 China CAR-T Therapy Market Size, 2017-2028
6.5.3 Japan CAR-T Therapy Market Size, 2017-2028
6.5.4 South Korea CAR-T Therapy Market Size, 2017-2028
6.5.5 Southeast Asia CAR-T Therapy Market Size, 2017-2028
6.5.6 India CAR-T Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America CAR-T Therapy Revenue, 2017-2028
6.6.2 Brazil CAR-T Therapy Market Size, 2017-2028
6.6.3 Argentina CAR-T Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR-T Therapy Revenue, 2017-2028
6.7.2 Turkey CAR-T Therapy Market Size, 2017-2028
6.7.3 Israel CAR-T Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia CAR-T Therapy Market Size, 2017-2028
6.7.5 UAE CAR-T Therapy Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG CAR-T Therapy Major Product Offerings
7.1.4 Novartis AG CAR-T Therapy Revenue in Global Market (2017-2022)
7.1.5 Novartis AG Key News
7.2 Kite Pharma
7.2.1 Kite Pharma Corporate Summary
7.2.2 Kite Pharma Business Overview
7.2.3 Kite Pharma CAR-T Therapy Major Product Offerings
7.2.4 Kite Pharma CAR-T Therapy Revenue in Global Market (2017-2022)
7.2.5 Kite Pharma Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer CAR-T Therapy Major Product Offerings
7.3.4 Pfizer CAR-T Therapy Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Juno Therapeutics
7.4.1 Juno Therapeutics Corporate Summary
7.4.2 Juno Therapeutics Business Overview
7.4.3 Juno Therapeutics CAR-T Therapy Major Product Offerings
7.4.4 Juno Therapeutics CAR-T Therapy Revenue in Global Market (2017-2022)
7.4.5 Juno Therapeutics Key News
7.5 Celgene Corporation
7.5.1 Celgene Corporation Corporate Summary
7.5.2 Celgene Corporation Business Overview
7.5.3 Celgene Corporation CAR-T Therapy Major Product Offerings
7.5.4 Celgene Corporation CAR-T Therapy Revenue in Global Market (2017-2022)
7.5.5 Celgene Corporation Key News
7.6 CARsgen Therapeutics
7.6.1 CARsgen Therapeutics Corporate Summary
7.6.2 CARsgen Therapeutics Business Overview
7.6.3 CARsgen Therapeutics CAR-T Therapy Major Product Offerings
7.6.4 CARsgen Therapeutics CAR-T Therapy Revenue in Global Market (2017-2022)
7.6.5 CARsgen Therapeutics Key News
7.7 Sorrento Therapeutics
7.7.1 Sorrento Therapeutics Corporate Summary
7.7.2 Sorrento Therapeutics Business Overview
7.7.3 Sorrento Therapeutics CAR-T Therapy Major Product Offerings
7.7.4 Sorrento Therapeutics CAR-T Therapy Revenue in Global Market (2017-2022)
7.7.5 Sorrento Therapeutics Key News
7.8 Legend Biotech
7.8.1 Legend Biotech Corporate Summary
7.8.2 Legend Biotech Business Overview
7.8.3 Legend Biotech CAR-T Therapy Major Product Offerings
7.8.4 Legend Biotech CAR-T Therapy Revenue in Global Market (2017-2022)
7.8.5 Legend Biotech Key News
7.9 Atara Biotherapeutics
7.9.1 Atara Biotherapeutics Corporate Summary
7.9.2 Atara Biotherapeutics Business Overview
7.9.3 Atara Biotherapeutics CAR-T Therapy Major Product Offerings
7.9.4 Atara Biotherapeutics CAR-T Therapy Revenue in Global Market (2017-2022)
7.9.5 Atara Biotherapeutics Key News
7.10 Aurora Biopharma
7.10.1 Aurora Biopharma Corporate Summary
7.10.2 Aurora Biopharma Business Overview
7.10.3 Aurora Biopharma CAR-T Therapy Major Product Offerings
7.10.4 Aurora Biopharma CAR-T Therapy Revenue in Global Market (2017-2022)
7.10.5 Aurora Biopharma Key News
7.11 Autolus Therapeutics PLC
7.11.1 Autolus Therapeutics PLC Corporate Summary
7.11.2 Autolus Therapeutics PLC Business Overview
7.11.3 Autolus Therapeutics PLC CAR-T Therapy Major Product Offerings
7.11.4 Autolus Therapeutics PLC CAR-T Therapy Revenue in Global Market (2017-2022)
7.11.5 Autolus Therapeutics PLC Key News
7.12 Bluebird
7.12.1 Bluebird Corporate Summary
7.12.2 Bluebird Business Overview
7.12.3 Bluebird CAR-T Therapy Major Product Offerings
7.12.4 Bluebird CAR-T Therapy Revenue in Global Market (2017-2022)
7.12.5 Bluebird Key News
7.13 Carina Biotech
7.13.1 Carina Biotech Corporate Summary
7.13.2 Carina Biotech Business Overview
7.13.3 Carina Biotech CAR-T Therapy Major Product Offerings
7.13.4 Carina Biotech CAR-T Therapy Revenue in Global Market (2017-2022)
7.13.5 Carina Biotech Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 CAR-T Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR-T Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CAR-T THERAPY OVERALL MARKET SIZE
2.1 Global CAR-T Therapy Market Size: 2021 VS 2028
2.2 Global CAR-T Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top CAR-T Therapy Players in Global Market
3.2 Top Global CAR-T Therapy Companies Ranked by Revenue
3.3 Global CAR-T Therapy Revenue by Companies
3.4 Top 3 and Top 5 CAR-T Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies CAR-T Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR-T Therapy Players in Global Market
3.6.1 List of Global Tier 1 CAR-T Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR-T Therapy Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global CAR-T Therapy Market Size Markets, 2021 & 2028
4.1.2 CD19
4.1.3 CD22
4.1.4 Other
4.2 By Type - Global CAR-T Therapy Revenue & Forecasts
4.2.1 By Type - Global CAR-T Therapy Revenue, 2017-2022
4.2.2 By Type - Global CAR-T Therapy Revenue, 2023-2028
4.2.3 By Type - Global CAR-T Therapy Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global CAR-T Therapy Market Size, 2021 & 2028
5.1.2 Acute Lymphocytic Leukemia
5.1.3 Diffuse Large B Cell Lymphoma
5.1.4 Follicular Lymphoma
5.1.5 Chronic Lymphocytic Leukemia
5.1.6 Multiple Myeloma
5.1.7 Other
5.2 By Application - Global CAR-T Therapy Revenue & Forecasts
5.2.1 By Application - Global CAR-T Therapy Revenue, 2017-2022
5.2.2 By Application - Global CAR-T Therapy Revenue, 2023-2028
5.2.3 By Application - Global CAR-T Therapy Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global CAR-T Therapy Market Size, 2021 & 2028
6.2 By Region - Global CAR-T Therapy Revenue & Forecasts
6.2.1 By Region - Global CAR-T Therapy Revenue, 2017-2022
6.2.2 By Region - Global CAR-T Therapy Revenue, 2023-2028
6.2.3 By Region - Global CAR-T Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America CAR-T Therapy Revenue, 2017-2028
6.3.2 US CAR-T Therapy Market Size, 2017-2028
6.3.3 Canada CAR-T Therapy Market Size, 2017-2028
6.3.4 Mexico CAR-T Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe CAR-T Therapy Revenue, 2017-2028
6.4.2 Germany CAR-T Therapy Market Size, 2017-2028
6.4.3 France CAR-T Therapy Market Size, 2017-2028
6.4.4 U.K. CAR-T Therapy Market Size, 2017-2028
6.4.5 Italy CAR-T Therapy Market Size, 2017-2028
6.4.6 Russia CAR-T Therapy Market Size, 2017-2028
6.4.7 Nordic Countries CAR-T Therapy Market Size, 2017-2028
6.4.8 Benelux CAR-T Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia CAR-T Therapy Revenue, 2017-2028
6.5.2 China CAR-T Therapy Market Size, 2017-2028
6.5.3 Japan CAR-T Therapy Market Size, 2017-2028
6.5.4 South Korea CAR-T Therapy Market Size, 2017-2028
6.5.5 Southeast Asia CAR-T Therapy Market Size, 2017-2028
6.5.6 India CAR-T Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America CAR-T Therapy Revenue, 2017-2028
6.6.2 Brazil CAR-T Therapy Market Size, 2017-2028
6.6.3 Argentina CAR-T Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR-T Therapy Revenue, 2017-2028
6.7.2 Turkey CAR-T Therapy Market Size, 2017-2028
6.7.3 Israel CAR-T Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia CAR-T Therapy Market Size, 2017-2028
6.7.5 UAE CAR-T Therapy Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG CAR-T Therapy Major Product Offerings
7.1.4 Novartis AG CAR-T Therapy Revenue in Global Market (2017-2022)
7.1.5 Novartis AG Key News
7.2 Kite Pharma
7.2.1 Kite Pharma Corporate Summary
7.2.2 Kite Pharma Business Overview
7.2.3 Kite Pharma CAR-T Therapy Major Product Offerings
7.2.4 Kite Pharma CAR-T Therapy Revenue in Global Market (2017-2022)
7.2.5 Kite Pharma Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer CAR-T Therapy Major Product Offerings
7.3.4 Pfizer CAR-T Therapy Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Juno Therapeutics
7.4.1 Juno Therapeutics Corporate Summary
7.4.2 Juno Therapeutics Business Overview
7.4.3 Juno Therapeutics CAR-T Therapy Major Product Offerings
7.4.4 Juno Therapeutics CAR-T Therapy Revenue in Global Market (2017-2022)
7.4.5 Juno Therapeutics Key News
7.5 Celgene Corporation
7.5.1 Celgene Corporation Corporate Summary
7.5.2 Celgene Corporation Business Overview
7.5.3 Celgene Corporation CAR-T Therapy Major Product Offerings
7.5.4 Celgene Corporation CAR-T Therapy Revenue in Global Market (2017-2022)
7.5.5 Celgene Corporation Key News
7.6 CARsgen Therapeutics
7.6.1 CARsgen Therapeutics Corporate Summary
7.6.2 CARsgen Therapeutics Business Overview
7.6.3 CARsgen Therapeutics CAR-T Therapy Major Product Offerings
7.6.4 CARsgen Therapeutics CAR-T Therapy Revenue in Global Market (2017-2022)
7.6.5 CARsgen Therapeutics Key News
7.7 Sorrento Therapeutics
7.7.1 Sorrento Therapeutics Corporate Summary
7.7.2 Sorrento Therapeutics Business Overview
7.7.3 Sorrento Therapeutics CAR-T Therapy Major Product Offerings
7.7.4 Sorrento Therapeutics CAR-T Therapy Revenue in Global Market (2017-2022)
7.7.5 Sorrento Therapeutics Key News
7.8 Legend Biotech
7.8.1 Legend Biotech Corporate Summary
7.8.2 Legend Biotech Business Overview
7.8.3 Legend Biotech CAR-T Therapy Major Product Offerings
7.8.4 Legend Biotech CAR-T Therapy Revenue in Global Market (2017-2022)
7.8.5 Legend Biotech Key News
7.9 Atara Biotherapeutics
7.9.1 Atara Biotherapeutics Corporate Summary
7.9.2 Atara Biotherapeutics Business Overview
7.9.3 Atara Biotherapeutics CAR-T Therapy Major Product Offerings
7.9.4 Atara Biotherapeutics CAR-T Therapy Revenue in Global Market (2017-2022)
7.9.5 Atara Biotherapeutics Key News
7.10 Aurora Biopharma
7.10.1 Aurora Biopharma Corporate Summary
7.10.2 Aurora Biopharma Business Overview
7.10.3 Aurora Biopharma CAR-T Therapy Major Product Offerings
7.10.4 Aurora Biopharma CAR-T Therapy Revenue in Global Market (2017-2022)
7.10.5 Aurora Biopharma Key News
7.11 Autolus Therapeutics PLC
7.11.1 Autolus Therapeutics PLC Corporate Summary
7.11.2 Autolus Therapeutics PLC Business Overview
7.11.3 Autolus Therapeutics PLC CAR-T Therapy Major Product Offerings
7.11.4 Autolus Therapeutics PLC CAR-T Therapy Revenue in Global Market (2017-2022)
7.11.5 Autolus Therapeutics PLC Key News
7.12 Bluebird
7.12.1 Bluebird Corporate Summary
7.12.2 Bluebird Business Overview
7.12.3 Bluebird CAR-T Therapy Major Product Offerings
7.12.4 Bluebird CAR-T Therapy Revenue in Global Market (2017-2022)
7.12.5 Bluebird Key News
7.13 Carina Biotech
7.13.1 Carina Biotech Corporate Summary
7.13.2 Carina Biotech Business Overview
7.13.3 Carina Biotech CAR-T Therapy Major Product Offerings
7.13.4 Carina Biotech CAR-T Therapy Revenue in Global Market (2017-2022)
7.13.5 Carina Biotech Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. CAR-T Therapy Market Opportunities & Trends in Global Market
Table 2. CAR-T Therapy Market Drivers in Global Market
Table 3. CAR-T Therapy Market Restraints in Global Market
Table 4. Key Players of CAR-T Therapy in Global Market
Table 5. Top CAR-T Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global CAR-T Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global CAR-T Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies CAR-T Therapy Product Type
Table 9. List of Global Tier 1 CAR-T Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR-T Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global CAR-T Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - CAR-T Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - CAR-T Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global CAR-T Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - CAR-T Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - CAR-T Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global CAR-T Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global CAR-T Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global CAR-T Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America CAR-T Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America CAR-T Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe CAR-T Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe CAR-T Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia CAR-T Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia CAR-T Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America CAR-T Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America CAR-T Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa CAR-T Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa CAR-T Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG CAR-T Therapy Product Offerings
Table 32. Novartis AG CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Kite Pharma Corporate Summary
Table 34. Kite Pharma CAR-T Therapy Product Offerings
Table 35. Kite Pharma CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer CAR-T Therapy Product Offerings
Table 38. Pfizer CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Juno Therapeutics Corporate Summary
Table 40. Juno Therapeutics CAR-T Therapy Product Offerings
Table 41. Juno Therapeutics CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Celgene Corporation Corporate Summary
Table 43. Celgene Corporation CAR-T Therapy Product Offerings
Table 44. Celgene Corporation CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 45. CARsgen Therapeutics Corporate Summary
Table 46. CARsgen Therapeutics CAR-T Therapy Product Offerings
Table 47. CARsgen Therapeutics CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Sorrento Therapeutics Corporate Summary
Table 49. Sorrento Therapeutics CAR-T Therapy Product Offerings
Table 50. Sorrento Therapeutics CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Legend Biotech Corporate Summary
Table 52. Legend Biotech CAR-T Therapy Product Offerings
Table 53. Legend Biotech CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Atara Biotherapeutics Corporate Summary
Table 55. Atara Biotherapeutics CAR-T Therapy Product Offerings
Table 56. Atara Biotherapeutics CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 57. Aurora Biopharma Corporate Summary
Table 58. Aurora Biopharma CAR-T Therapy Product Offerings
Table 59. Aurora Biopharma CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 60. Autolus Therapeutics PLC Corporate Summary
Table 61. Autolus Therapeutics PLC CAR-T Therapy Product Offerings
Table 62. Autolus Therapeutics PLC CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 63. Bluebird Corporate Summary
Table 64. Bluebird CAR-T Therapy Product Offerings
Table 65. Bluebird CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 66. Carina Biotech Corporate Summary
Table 67. Carina Biotech CAR-T Therapy Product Offerings
Table 68. Carina Biotech CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 1. CAR-T Therapy Market Opportunities & Trends in Global Market
Table 2. CAR-T Therapy Market Drivers in Global Market
Table 3. CAR-T Therapy Market Restraints in Global Market
Table 4. Key Players of CAR-T Therapy in Global Market
Table 5. Top CAR-T Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global CAR-T Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global CAR-T Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies CAR-T Therapy Product Type
Table 9. List of Global Tier 1 CAR-T Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR-T Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global CAR-T Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - CAR-T Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - CAR-T Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global CAR-T Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - CAR-T Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - CAR-T Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global CAR-T Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global CAR-T Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global CAR-T Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America CAR-T Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America CAR-T Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe CAR-T Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe CAR-T Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia CAR-T Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia CAR-T Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America CAR-T Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America CAR-T Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa CAR-T Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa CAR-T Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG CAR-T Therapy Product Offerings
Table 32. Novartis AG CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Kite Pharma Corporate Summary
Table 34. Kite Pharma CAR-T Therapy Product Offerings
Table 35. Kite Pharma CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer CAR-T Therapy Product Offerings
Table 38. Pfizer CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Juno Therapeutics Corporate Summary
Table 40. Juno Therapeutics CAR-T Therapy Product Offerings
Table 41. Juno Therapeutics CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Celgene Corporation Corporate Summary
Table 43. Celgene Corporation CAR-T Therapy Product Offerings
Table 44. Celgene Corporation CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 45. CARsgen Therapeutics Corporate Summary
Table 46. CARsgen Therapeutics CAR-T Therapy Product Offerings
Table 47. CARsgen Therapeutics CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Sorrento Therapeutics Corporate Summary
Table 49. Sorrento Therapeutics CAR-T Therapy Product Offerings
Table 50. Sorrento Therapeutics CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Legend Biotech Corporate Summary
Table 52. Legend Biotech CAR-T Therapy Product Offerings
Table 53. Legend Biotech CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Atara Biotherapeutics Corporate Summary
Table 55. Atara Biotherapeutics CAR-T Therapy Product Offerings
Table 56. Atara Biotherapeutics CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 57. Aurora Biopharma Corporate Summary
Table 58. Aurora Biopharma CAR-T Therapy Product Offerings
Table 59. Aurora Biopharma CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 60. Autolus Therapeutics PLC Corporate Summary
Table 61. Autolus Therapeutics PLC CAR-T Therapy Product Offerings
Table 62. Autolus Therapeutics PLC CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 63. Bluebird Corporate Summary
Table 64. Bluebird CAR-T Therapy Product Offerings
Table 65. Bluebird CAR-T Therapy Revenue (US$, Mn), (2017-2022)
Table 66. Carina Biotech Corporate Summary
Table 67. Carina Biotech CAR-T Therapy Product Offerings
Table 68. Carina Biotech CAR-T Therapy Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. CAR-T Therapy Segment by Type in 2021
Figure 2. CAR-T Therapy Segment by Application in 2021
Figure 3. Global CAR-T Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global CAR-T Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CAR-T Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR-T Therapy Revenue in 2021
Figure 8. By Type - Global CAR-T Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global CAR-T Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global CAR-T Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America CAR-T Therapy Revenue Market Share, 2017-2028
Figure 12. US CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe CAR-T Therapy Revenue Market Share, 2017-2028
Figure 16. Germany CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia CAR-T Therapy Revenue Market Share, 2017-2028
Figure 24. China CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America CAR-T Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa CAR-T Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis AG CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Kite Pharma CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Juno Therapeutics CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celgene Corporation CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. CARsgen Therapeutics CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sorrento Therapeutics CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Legend Biotech CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Atara Biotherapeutics CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Aurora Biopharma CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Autolus Therapeutics PLC CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Bluebird CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Carina Biotech CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. CAR-T Therapy Segment by Type in 2021
Figure 2. CAR-T Therapy Segment by Application in 2021
Figure 3. Global CAR-T Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global CAR-T Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CAR-T Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR-T Therapy Revenue in 2021
Figure 8. By Type - Global CAR-T Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global CAR-T Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global CAR-T Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America CAR-T Therapy Revenue Market Share, 2017-2028
Figure 12. US CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe CAR-T Therapy Revenue Market Share, 2017-2028
Figure 16. Germany CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia CAR-T Therapy Revenue Market Share, 2017-2028
Figure 24. China CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America CAR-T Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa CAR-T Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE CAR-T Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis AG CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Kite Pharma CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Juno Therapeutics CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celgene Corporation CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. CARsgen Therapeutics CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sorrento Therapeutics CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Legend Biotech CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Atara Biotherapeutics CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Aurora Biopharma CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Autolus Therapeutics PLC CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Bluebird CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Carina Biotech CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)